Advertisement
BDMD vs CERS
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BDMD is a StrongBuy and CERS is a Hold.
| BDMD | CERS | BDMD / CERS | |
| Capitalization | 35.2M | 502M | 7% |
| EBITDA | -14.29M | 2.91M | -491% |
| Gain YTD | -19.118 | 20.874 | -92% |
| P/E Ratio | 3.16 | N/A | - |
| Revenue | 24.5M | 222M | 11% |
| Total Cash | 289K | 56.3M | 1% |
| Total Debt | 14.2M | 76.8M | 18% |
CERS | ||
|---|---|---|
OUTLOOK RATING 1..100 | 66 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 39 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 94 | |
PRICE GROWTH RATING 1..100 | 39 | |
P/E GROWTH RATING 1..100 | 100 | |
SEASONALITY SCORE 1..100 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| BDMD | CERS | |
|---|---|---|
| RSI ODDS (%) | N/A | 5 days ago 90% |
| Stochastic ODDS (%) | 2 days ago 54% | 2 days ago 82% |
| Momentum ODDS (%) | 2 days ago 43% | 2 days ago 79% |
| MACD ODDS (%) | 2 days ago 27% | 2 days ago 81% |
| TrendWeek ODDS (%) | 2 days ago 60% | 2 days ago 84% |
| TrendMonth ODDS (%) | 2 days ago 68% | 2 days ago 81% |
| Advances ODDS (%) | 4 days ago 59% | 18 days ago 75% |
| Declines ODDS (%) | 17 days ago 82% | 3 days ago 82% |
| BollingerBands ODDS (%) | 5 days ago 30% | N/A |
| Aroon ODDS (%) | 2 days ago 23% | 2 days ago 87% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BDMD’s FA Score shows that 0 FA rating(s) are green while CERS’s FA Score has 0 green FA rating(s).
- BDMD’s FA Score: 0 green, 5 red.
- CERS’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BDMD’s TA Score shows that 3 TA indicator(s) are bullish while CERS’s TA Score has 3 bullish TA indicator(s).
- BDMD’s TA Score: 3 bullish, 6 bearish.
- CERS’s TA Score: 3 bullish, 5 bearish.
Price Growth
BDMD (@Medical/Nursing Services) experienced а +0.92% price change this week, while CERS (@Medical/Nursing Services) price change was -3.86% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -5.01%. For the same industry, the average monthly price growth was -8.95%, and the average quarterly price growth was -6.66%.
Reported Earning Dates
CERS is expected to report earnings on Oct 29, 2026.
Industries' Descriptions
@Medical/Nursing Services (-5.01% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
Advertisement
BDMD and
Correlation & Price change
A.I.dvisor tells us that BDMD and INFU have been poorly correlated (+22% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BDMD and INFU's prices will move in lockstep.
| Ticker / NAME | Correlation To BDMD | 1D Price Change % | ||
|---|---|---|---|---|
| BDMD | 100% | +1.85% | ||
| INFU - BDMD | 22% Poorly correlated | +0.25% | ||
| NVCR - BDMD | 21% Poorly correlated | +1.04% | ||
| DCTH - BDMD | 21% Poorly correlated | +0.70% | ||
| CERS - BDMD | 21% Poorly correlated | +1.22% | ||
| PAVM - BDMD | 12% Poorly correlated | -2.11% | ||
More | ||||
CERS and
Correlation & Price change
A.I.dvisor indicates that over the last year, CERS has been loosely correlated with ICUI. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if CERS jumps, then ICUI could also see price increases.
| Ticker / NAME | Correlation To CERS | 1D Price Change % | ||
|---|---|---|---|---|
| CERS | 100% | +1.22% | ||
| ICUI - CERS | 46% Loosely correlated | -0.50% | ||
| UTMD - CERS | 45% Loosely correlated | +0.10% | ||
| BLFS - CERS | 45% Loosely correlated | +0.09% | ||
| RVTY - CERS | 44% Loosely correlated | +2.79% | ||
| ATRC - CERS | 43% Loosely correlated | +2.98% | ||
More | ||||